Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

Fasting Increases Tobramycin Oral Absorption in Mice

(2010) L. De Leo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors

(2010) Plinio C. Casarotto et al.   BEHAVIOURAL PHARMACOLOGY

The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

(2010) Daniele Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats

(2010) Andrew J. Hill et al.   EPILEPSIA

Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins

(2010) Aurelia Tubaro et al.   FITOTERAPIA

Cannabis-based medicines in multiple sclerosis – A review of clinical studies

(2010) David J. Rog   IMMUNOBIOLOGY

Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms

(2010) Thomas Perrier et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery

(2010) Dennis A. Smith et al.   NATURE REVIEWS DRUG DISCOVERY

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

(2010) R. G. Pertwee et al.   PHARMACOLOGICAL REVIEWS

Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice

(2010) Felipe V. Gomes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

(2009) MG Cascio et al.   BRITISH JOURNAL OF PHARMACOLOGY

Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice

(2009) Gernot Riedel et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol: A Promising Drug for Neurodegenerative Disorders?

(2009) Teresa Iuvone et al.   CNS Neuroscience & Therapeutics

Pleiotropic Effects of Rimonabant: Clinical Implications

(2009) Jean-Pierre Despres   CURRENT PHARMACEUTICAL DESIGN

Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models

(2009) Francis Rodriguez Bambico et al.   CURRENT PHARMACEUTICAL DESIGN

Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: Compound-specific and area-specific distribution within the brain

(2009) I. Barna et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

S39-02 Antipsychotic effects of cannabidiol

(2009) F.M. Leweke et al.   EUROPEAN PSYCHIATRY

Examining the roles of cannabinoids in pain and other therapeutic indications: a review

(2009) Dana Turcotte et al.   EXPERT OPINION ON PHARMACOTHERAPY

Melancholic features related to rimonabant

(2009) Bernardo de Mattos Viana et al.   GENERAL HOSPITAL PSYCHIATRY

Delivery of Cisplatin from Pluronic Co-polymer Systems: Liposome Inclusion and Alginate Coupling

(2009) Jia-You Fang et al.   JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

(2009) L. S. Whyte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

(2009) Alexia Thomas et al.   PSYCHOPHARMACOLOGY

Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

(2008) S. Syvanen et al.   DRUG METABOLISM AND DISPOSITION

Antibacterial Cannabinoids fromCannabis sativa: A Structure−Activity Study

(2008) Giovanni Appendino et al.   JOURNAL OF NATURAL PRODUCTS

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

GPR55: a new member of the cannabinoid receptor clan?

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

The orphan receptor GPR55 is a novel cannabinoid receptor

(2007) E Ryberg et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY